Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma

Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma

Despite recent advances in diagnosis and treatment, glioblastoma (GBM) represents the most common and aggressive brain tumor in the adult population, urging identification of new rational therapeutic targets. Galectins, a family of glycan-binding proteins, are highly expressed in the tumor microenvi...

Full description

Bibliographic Details
Main Authors: Guillermo A. Videla-Richardson, Olivia Morris-Hanon, Nicolás I. Torres, Myrian I. Esquivel, Mariana B. Vera, Luisina B. Ripari, Diego O. Croci, Gustavo E. Sevlever, Gabriel A. Rabinovich
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
central nervous system
glioblastoma
galectins
glycans
angiogenesis
immunomodulation
Online Access:https://www.mdpi.com/1422-0067/23/1/316

Internet

https://www.mdpi.com/1422-0067/23/1/316

Similar Items